Poseida Therapeutics (PSTX) Stock Chart & Stock Price History → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free PSTX Stock Alerts $3.19 -0.16 (-4.78%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Poseida Therapeutics Stock Price Performance5 Day Performance+13.52%1 Month Performance+59.50%3 Month Performance-12.84%6 Month Performance+40.53%Year-To-Date Performance-5.06%1 Year Performance+26.59% Receive PSTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Poseida Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Monument Traders AllianceMake this ONE trade on Tuesday at 2 p.m. EST!Every time the U.S. Government releases jobs, inflation, GDP and other Economic Reports… Use The JOLTS Loophole to target up to 253%... 327%... Even 383% Overnight Profits!Discover The Secret Loophole BEFORE Tuesday! PSTX Stock Chart for Saturday, May, 18, 2024 PSTX Chart by TradingView Poseida Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$3.35$3.19-4.63%$3.38$3.12520,312 shs$309.30 million05/16/2024$3.46$3.35-3.32%$3.55$3.30632,755 shs$324.23 million05/15/2024$2.92$3.46+18.49%$3.54$2.961.23 million shs$335.38 million05/14/2024$2.81$2.92+3.91%$2.98$2.85484,048 shs$283.04 million05/13/2024$2.65$2.81+6.24%$2.84$2.67238,855 shs$272.37 million05/10/2024$2.71$2.65-2.40%$2.78$2.59368,651 shs$256.38 million Get the Latest News and Ratings for PSTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Poseida Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$2.71$2.71$2.76$2.61417,831 shs$262.68 million05/08/2024$2.92$2.71-7.19%$2.91$2.68359,109 shs$262.68 million05/07/2024$2.83$2.92+3.18%$2.93$2.80385,765 shs$283.04 million05/06/2024$2.87$2.83-1.39%$3.00$2.81545,898 shs$274.31 million05/03/2024$2.79$2.87+2.87%$2.99$2.82549,737 shs$278.19 million05/02/2024$2.77$2.79+0.72%$2.97$2.731.36 million shs$270.44 million05/01/2024$2.42$2.77+14.46%$3.00$2.692.86 million shs$268.50 million04/30/2024$2.32$2.42+4.31%$2.50$2.27540,003 shs$234.57 million04/29/2024$2.13$2.32+8.92%$2.33$2.13327,961 shs$224.88 million04/26/2024$2.05$2.13+3.90%$2.14$2.03461,187 shs$205.52 million04/25/2024$2.07$2.05-0.97%$2.08$1.98283,232 shs$197.80 million04/24/2024$2.16$2.07-4.17%$2.17$2.02456,313 shs$199.73 million04/23/2024$2.16$2.16+0.23%$2.27$2.12422,964 shs$208.42 million04/22/2024$2.02$2.16+6.68%$2.16$2.00553,519 shs$207.94 million04/19/2024$2.00$2.02+1.00%$2.07$1.95641,417 shs$194.91 million04/18/2024$2.04$2.00-1.96%$2.16$2.00518,810 shs$192.98 million04/17/2024$2.03$2.04+0.49%$2.08$1.91976,891 shs$196.84 million04/16/2024$2.43$2.03-16.46%$2.21$1.871.44 million shs$195.88 million04/15/2024$2.73$2.43-10.99%$2.71$2.42590,998 shs$234.47 million04/12/2024$2.91$2.73-6.19%$2.92$2.66340,878 shs$263.42 million04/11/2024$2.79$2.91+4.30%$2.91$2.75332,775 shs$280.78 million04/10/2024$3.01$2.79-7.31%$2.93$2.77517,865 shs$269.21 million04/09/2024$2.97$3.01+1.35%$3.02$2.88397,397 shs$290.44 million04/08/2024$2.99$2.97-0.67%$3.05$2.93420,305 shs$286.58 million04/05/2024$3.07$2.99-2.61%$3.16$2.98438,145 shs$288.51 million04/04/2024$3.06$3.07+0.33%$3.22$3.04381,843 shs$296.22 million04/03/2024$2.90$3.06+5.52%$3.10$2.88448,444 shs$295.26 million04/02/2024$3.10$2.90-6.45%$3.04$2.87424,607 shs$279.82 million04/01/2024$3.19$3.10-2.82%$3.35$3.03608,655 shs$299.12 million03/29/2024$3.19$3.19$3.24$3.02698,380 shs$307.80 million03/28/2024$3.08$3.19+3.57%$3.24$3.02697,679 shs$307.80 million03/27/2024$2.81$3.08+9.61%$3.14$2.81671,088 shs$297.19 million03/26/2024$3.04$2.81-7.57%$3.12$2.81625,500 shs$271.13 million03/25/2024$3.11$3.04-2.25%$3.21$3.04563,077 shs$293.33 millionI’m afraid WWIII is a very real possibility (Ad)As one top U.S. cyber official claims: This [tech] is “the most powerful weapon of our time.” That's also why I've produced this new film.Take a look.03/22/2024$3.04$3.11+2.30%$3.18$3.02498,384 shs$300.08 million03/21/2024$2.97$3.04+2.36%$3.18$2.95745,469 shs$293.33 million03/20/2024$2.91$2.97+2.06%$3.08$2.80915,404 shs$286.58 million03/19/2024$3.06$2.91-4.90%$3.10$2.89522,663 shs$280.79 million03/18/2024$3.22$3.06-4.97%$3.28$3.06487,382 shs$295.26 million03/15/2024$3.24$3.22-0.62%$3.44$3.17934,629 shs$310.70 million03/14/2024$3.41$3.24-4.99%$3.38$3.04780,047 shs$312.63 million03/13/2024$3.17$3.41+7.57%$3.41$3.141.01 million shs$329.03 million03/12/2024$3.41$3.17-7.04%$3.46$3.122.25 million shs$305.87 million03/11/2024$4.07$3.41-16.22%$4.17$3.352.12 million shs$329.03 million03/08/2024$3.43$4.07+18.66%$4.08$2.862.67 million shs$389.17 million03/07/2024$3.59$3.43-4.46%$3.63$3.38597,151 shs$343.29 million03/06/2024$3.48$3.59+3.16%$3.78$3.48827,990 shs$343.28 million03/05/2024$3.69$3.48-5.56%$3.75$3.40760,615 shs$332.76 million03/04/2024$4.13$3.69-10.77%$4.18$3.68715,287 shs$352.36 million03/01/2024$3.96$4.13+4.29%$4.27$3.93686,849 shs$394.91 million02/29/2024$3.72$3.96+6.45%$4.05$3.71640,846 shs$378.66 million02/28/2024$3.77$3.72-1.33%$3.88$3.69575,752 shs$355.71 million02/27/2024$3.46$3.77+8.96%$3.82$3.48693,161 shs$360.50 million02/26/2024$3.25$3.46+6.46%$3.46$3.22387,760 shs$330.85 million02/23/2024$3.22$3.25+0.93%$3.29$3.19321,769 shs$310.77 million02/22/2024$3.34$3.22-3.59%$3.36$3.19403,099 shs$307.91 million02/21/2024$3.51$3.34-4.84%$3.60$3.30457,862 shs$319.37 million02/20/2024$3.66$3.51-4.10%$3.71$3.49413,469 shs$335.63 million02/19/2024$3.66$3.66$3.69$3.53458,200 shs$349.97 million Related Companies: STRO Stock Chart ADAP Stock Chart IVVD Stock Chart GLUE Stock Chart MGX Stock Chart SOPH Stock Chart CHRS Stock Chart CADL Stock Chart JSPR Stock Chart AGEN Stock Chart Receive PSTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Poseida Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PSTX) was last updated on 5/18/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceThe Presidential candidate you should REALLY be worried aboutStansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressWhat’s Really Next for America…Porter & CompanyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Poseida Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.